[Risk factors for pleural lung disease in children with juvenile idiopathic arthritis]

Yuan Hu1, Mei-Ping Lu, Li-Ping Teng

  • 1Department of Rheumatology, Immunology and Allergy, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. meipinglu@126.com.

Insights

Pleural lung disease (PLD) affects nearly 12% of children with juvenile idiopathic arthritis (JIA), particularly those with systemic JIA or specific age groups. Early detection via high-resolution chest CT is crucial for managing JIA-related lung complications.

Area of Science:

  • Pediatric Rheumatology
  • Pulmonology
  • Medical Imaging

Background:

  • Juvenile idiopathic arthritis (JIA) is a chronic inflammatory condition affecting children.
  • Pleural lung disease (PLD) is a potential complication of JIA, necessitating investigation into its risk factors and clinical presentation.
  • Early diagnosis and treatment are vital for managing JIA-associated PLD and improving patient outcomes.

Purpose of the Study:

  • To identify risk factors associated with pleural lung disease (PLD) in pediatric patients diagnosed with juvenile idiopathic arthritis (JIA).
  • To establish a foundation for the early detection and prompt management of PLD in children with JIA.

Main Methods:

  • Retrospective analysis of clinical data from 360 children diagnosed with JIA.
  • Categorization of patients into PLD and non-PLD groups based on diagnostic criteria.
  • Evaluation of clinical, imaging (chest X-ray, CT), and laboratory findings in JIA patients with PLD.

Main Results:

  • Pleural lung disease (PLD) was identified in 11.9% of the JIA cohort.
  • Interstitial pneumonitis and pleurisy/pleural effusion were the primary findings on chest imaging.
  • Higher incidence of PLD observed in children with systemic JIA, those under 3 years, and those 12 years or older.
  • PLD group showed increased rates of anemia, elevated white blood cell (WBC) count, elevated IgG levels, and positive rheumatoid factors or antinuclear antibodies compared to the non-PLD group.

Conclusions:

  • Pleural lung disease (PLD) in juvenile idiopathic arthritis (JIA) is more prevalent in systemic JIA cases and specific age groups (<3 years, ≥12 years).
  • Key indicators for PLD in JIA include anemia, elevated WBC count, elevated IgG, and positive autoimmune markers.
  • High-resolution chest CT is recommended for early diagnosis of PLD in JIA patients, as respiratory symptoms may be absent and chest X-rays can be normal.
Abstract

Related Concept Videos

Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.4K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
6.2K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
23
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
1.1K